{"transactions":[{"id":2388131,"issuer":{"id":3552,"kind":"organization","name":"Protagonist Therapeutics, Inc","symbol":"PTGX"},"owners":[{"id":44096,"kind":"person","name":"Kalkofen Donald A.","position":1,"cik":"0001771066","reported_name":"Kalkofen Donald A.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (right to buy)","published_at":"2022-02-18T00:26:56.000Z","date":"2022-02-15","kind":"grant","acquired":true,"shares":45000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The stock option vests in 48 equal monthly installments following the date of grant."}],"balance_after":45000,"derivative":{"exercise_price":28.73,"expiration_date":"2032-02-14","underlying":"Common Stock","underlying_shares":45000},"source":{"system":"sec-edgar","filing":"0001104659-22-024841","document":"tm227111-4_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1377121/000110465922024841/tm227111-4_4seq1.xml","form_type":"4"}},{"id":2388130,"issuer":{"id":3552,"kind":"organization","name":"Protagonist Therapeutics, Inc","symbol":"PTGX"},"owners":[{"id":44096,"kind":"person","name":"Kalkofen Donald A.","position":1,"cik":"0001771066","reported_name":"Kalkofen Donald A.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2022-02-18T00:26:56.000Z","date":"2022-02-15","kind":"grant","acquired":true,"shares":7500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents grant of restricted stock units payable solely in common stock that will vest in three annual installments on February 15, 2023, 2024 and 2025."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes an aggregate of 635 shares acquired by the Reporting Person under the Issuer's 2016 Employee Stock Purchase Plan on March 9, 2021."}],"balance_after":18521,"source":{"system":"sec-edgar","filing":"0001104659-22-024841","document":"tm227111-4_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1377121/000110465922024841/tm227111-4_4seq1.xml","form_type":"4"}},{"id":2829429,"issuer":{"id":3552,"kind":"organization","name":"Protagonist Therapeutics, Inc","symbol":"PTGX"},"owners":[{"id":44096,"kind":"person","name":"Kalkofen Donald A.","position":1,"cik":"0001771066","reported_name":"Kalkofen Donald A.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (right to buy)","published_at":"2021-02-26T23:29:39.000Z","date":"2021-02-26","kind":"grant","acquired":true,"shares":55000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The stock option vests in 48 equal monthly installments following the date of grant."}],"balance_after":55000,"derivative":{"exercise_price":23.57,"expiration_date":"2031-02-25","underlying":"Common Stock","underlying_shares":55000},"source":{"system":"sec-edgar","filing":"0001209191-21-014973","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1377121/000120919121014973/doc4.xml","form_type":"4"}},{"id":2829428,"issuer":{"id":3552,"kind":"organization","name":"Protagonist Therapeutics, Inc","symbol":"PTGX"},"owners":[{"id":44096,"kind":"person","name":"Kalkofen Donald A.","position":1,"cik":"0001771066","reported_name":"Kalkofen Donald A.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2021-02-26T23:29:39.000Z","date":"2021-02-26","kind":"grant","acquired":true,"shares":7500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents grant of restricted stock units payable solely in common stock that will become fully vested on February 26, 2024."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes an aggregate of 1,711 shares acquired by the Reporting Person under the Issuer's 2016 Employee Stock Purchase Plan on March 9, 2020 and September 9, 2020."}],"balance_after":10386,"source":{"system":"sec-edgar","filing":"0001209191-21-014973","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1377121/000120919121014973/doc4.xml","form_type":"4"}},{"id":3241037,"issuer":{"id":3552,"kind":"organization","name":"Protagonist Therapeutics, Inc","symbol":"PTGX"},"owners":[{"id":44096,"kind":"person","name":"Kalkofen Donald A.","position":1,"cik":"0001771066","reported_name":"Kalkofen Donald A.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (right to buy)","published_at":"2020-02-28T22:45:37.000Z","date":"2020-02-28","kind":"grant","acquired":true,"shares":55000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option vests in 48 equal monthly installments following the date of grant."}],"balance_after":55000,"derivative":{"exercise_price":7.8,"expiration_date":"2030-02-27","underlying":"Common Stock","underlying_shares":55000},"source":{"system":"sec-edgar","filing":"0001209191-20-014090","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1377121/000120919120014090/doc4.xml","form_type":"4"}},{"id":3353947,"issuer":{"id":3552,"kind":"organization","name":"Protagonist Therapeutics, Inc","symbol":"PTGX"},"owners":[{"id":44096,"kind":"person","name":"Kalkofen Donald A.","position":1,"cik":"0001771066","reported_name":"Kalkofen Donald A.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2019-12-03T23:11:32.000Z","date":"2019-12-03","kind":"purchase","acquired":true,"shares":562,"price":5.09,"value":2860.58,"ownership":{"direct":true},"balance_after":1175,"source":{"system":"sec-edgar","filing":"0001209191-19-058800","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1377121/000120919119058800/doc4.xml","form_type":"4"}},{"id":3353946,"issuer":{"id":3552,"kind":"organization","name":"Protagonist Therapeutics, Inc","symbol":"PTGX"},"owners":[{"id":44096,"kind":"person","name":"Kalkofen Donald A.","position":1,"cik":"0001771066","reported_name":"Kalkofen Donald A.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2019-12-03T23:11:32.000Z","date":"2019-12-03","kind":"purchase","acquired":true,"shares":613,"price":5.1,"value":3126.3,"ownership":{"direct":true},"balance_after":613,"source":{"system":"sec-edgar","filing":"0001209191-19-058800","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1377121/000120919119058800/doc4.xml","form_type":"4"}},{"id":3504457,"issuer":{"id":3552,"kind":"organization","name":"Protagonist Therapeutics, Inc","symbol":"PTGX"},"owners":[{"id":44096,"kind":"person","name":"Kalkofen Donald A.","position":1,"cik":"0001771066","reported_name":"Kalkofen Donald A.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (right to buy)","published_at":"2019-06-03T23:40:10.000Z","date":"2019-05-31","kind":"grant","acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option vests over a four-year period with 25% of the shares underlying the option vesting on the one-year anniversary of the vesting commencement date of May 28, 2019, and the balance vesting in equal monthly installments over the following 36 months."}],"balance_after":100000,"derivative":{"exercise_price":10.06,"expiration_date":"2029-05-30","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001209191-19-034082","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1377121/000120919119034082/doc4.xml","form_type":"4"}}]}